[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

SG42446A1 - Pharmaceutical composition method and device for preventing or treating dry eye or disease caused therefrom - Google Patents

Pharmaceutical composition method and device for preventing or treating dry eye or disease caused therefrom

Info

Publication number
SG42446A1
SG42446A1 SG1996011135A SG1996011135A SG42446A1 SG 42446 A1 SG42446 A1 SG 42446A1 SG 1996011135 A SG1996011135 A SG 1996011135A SG 1996011135 A SG1996011135 A SG 1996011135A SG 42446 A1 SG42446 A1 SG 42446A1
Authority
SG
Singapore
Prior art keywords
preventing
disease caused
dry eye
pharmaceutical composition
treating dry
Prior art date
Application number
SG1996011135A
Other languages
English (en)
Inventor
Noriko Watanabe
Takahiro Ogawa
Yasushi Okumura
Original Assignee
Senju Pharma Co
Tanabe Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Senju Pharma Co, Tanabe Seiyaku Co filed Critical Senju Pharma Co
Publication of SG42446A1 publication Critical patent/SG42446A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/01—Hydrocarbons
    • A61K31/015—Hydrocarbons carbocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/04—Artificial tears; Irrigation solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SG1996011135A 1995-11-15 1996-11-14 Pharmaceutical composition method and device for preventing or treating dry eye or disease caused therefrom SG42446A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP7322364A JP3059092B2 (ja) 1995-11-15 1995-11-15 ドライアイおよびドライアイを原因とする疾患の予防・治療剤

Publications (1)

Publication Number Publication Date
SG42446A1 true SG42446A1 (en) 1997-08-15

Family

ID=18142826

Family Applications (1)

Application Number Title Priority Date Filing Date
SG1996011135A SG42446A1 (en) 1995-11-15 1996-11-14 Pharmaceutical composition method and device for preventing or treating dry eye or disease caused therefrom

Country Status (11)

Country Link
US (1) US5830913A (ja)
EP (1) EP0774254B1 (ja)
JP (1) JP3059092B2 (ja)
KR (1) KR100425354B1 (ja)
CN (1) CN1078464C (ja)
AT (1) ATE179888T1 (ja)
CA (1) CA2190303C (ja)
DE (1) DE69602412T2 (ja)
ES (1) ES2131373T3 (ja)
SG (1) SG42446A1 (ja)
TW (1) TW411275B (ja)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10045343B4 (de) * 2000-09-14 2005-05-12 Neuhann, Tobias, Dr.med. Verwendung einer wässrigen Lösung oder Suspension zum Heilen des Hornhautepithels
JP4982643B2 (ja) * 2000-09-14 2012-07-25 株式会社林原 眼科用医薬組成物
JP3945625B2 (ja) 2001-03-30 2007-07-18 株式会社イーエムアイ 角膜上皮障害モデル動物及びそのモデル動物を用いた薬剤の評価方法並びにその評価方法を用いて選択された薬剤
US6831101B2 (en) * 2001-06-14 2004-12-14 Chemokine Therapeutics Corporation Tricyclic rantes receptor ligands
CN1219757C (zh) * 2001-07-16 2005-09-21 中国医药研究开发中心有限公司 磺化去氢松香酸盐及其制备方法和其用途
CA2460167A1 (en) * 2001-09-27 2003-04-10 Tanabe Seiyaku Co., Ltd. Aqueous ecabet sodium solution preparation
US20040220089A1 (en) * 2001-10-03 2004-11-04 Ellis Edward J. Ophthalmic preparation containing glycoprotein
US20050137166A1 (en) * 2003-12-19 2005-06-23 Alcon, Inc. Use of cooling agents to relieve mild ocular irritation and enhance comfort
EP1757603A4 (en) * 2004-05-11 2008-06-25 Santen Pharmaceutical Co Ltd THERAPEUTIC AGENT FOR KERAATOCONJUNCTIVITIS AFFECTION
US7247623B2 (en) * 2005-08-19 2007-07-24 Inspire Pharmaceuticals, Inc. Method of treating dry eye disease with non-drying antihistamines
US8343942B2 (en) * 2008-04-04 2013-01-01 University Of Utah Research Foundation Methods for treating interstitial cystitis
EP2389939A1 (en) * 2010-05-28 2011-11-30 Novagali Pharma S.A. Use of prostaglandins F2alpha and analogues for the healing of corneal and conjunctival lesions
US20130209531A1 (en) * 2010-06-08 2013-08-15 University Of Utah Research Foundation Applications of partially and fully sulfated hyaluronan
WO2012063237A2 (en) * 2010-11-08 2012-05-18 Healor Ltd. Buffered ophthalmic compositions and methods of use thereof
CA2821969A1 (en) * 2010-12-21 2012-06-28 Recopharma Ab Tear substitutes
KR101438744B1 (ko) * 2012-08-02 2014-09-15 전남대학교산학협력단 아디포넥틴을 유효성분으로 포함하는 안구건조증 또는 염증성 안구표면 질환의 예방 또는 치료용 조성물
JP6110037B2 (ja) * 2015-01-16 2017-04-05 生化学工業株式会社 コンドロイチン硫酸架橋体、並びにこれを含有する組成物、及び眼疾患処置剤
CN106581035A (zh) * 2016-12-06 2017-04-26 郑州郑先医药科技有限公司 一种治疗干眼病的西药组合物
CN106420797A (zh) * 2016-12-06 2017-02-22 郑州郑先医药科技有限公司 一种治疗干眼病的西药组合及其制备方法
US11229549B2 (en) * 2019-09-18 2022-01-25 Vance M. Thompson Tear transplantation and multi-part contact lens with absorbent portion
CN114588250B (zh) * 2022-03-18 2024-01-09 宁夏杞肽科技有限公司 枸杞糖肽在制备预防或治疗干眼症的药物中的用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK172690B1 (da) 1981-10-22 1999-05-31 Tanabe Seiyaku Co Analogifremgangsmåde til fremstilling af salte af sulfodehydroabietinsyre eller hydrater deraf
GB2107584A (en) 1981-10-22 1983-05-05 Tanabe Seiyaku Co Treatment of gastro-intestinal diseases
US5545617A (en) * 1993-11-12 1996-08-13 The Schepens Eye Research Institute, Inc. Therapeutic regulation of abnormal conjunctival goblet cell mucous secretion

Also Published As

Publication number Publication date
CN1078464C (zh) 2002-01-30
DE69602412T2 (de) 1999-11-18
DE69602412D1 (de) 1999-06-17
EP0774254A1 (en) 1997-05-21
CA2190303A1 (en) 1997-05-16
JP3059092B2 (ja) 2000-07-04
MX9605633A (es) 1998-05-31
JPH09136832A (ja) 1997-05-27
KR100425354B1 (ko) 2004-06-30
EP0774254B1 (en) 1999-05-12
CN1159323A (zh) 1997-09-17
ES2131373T3 (es) 1999-07-16
US5830913A (en) 1998-11-03
KR970025612A (ko) 1997-06-24
ATE179888T1 (de) 1999-05-15
CA2190303C (en) 2007-01-16
TW411275B (en) 2000-11-11

Similar Documents

Publication Publication Date Title
SG42446A1 (en) Pharmaceutical composition method and device for preventing or treating dry eye or disease caused therefrom
ES2150294T3 (es) Composicion de esteres de l-dopa.
AU3990797A (en) Sustained release formulation
ES2085886T3 (es) Composicion farmaceutica de liberacion contenida.
HU9600834D0 (en) Quinazoline derivatives
LU90969I2 (fr) Compositions ophtalmiques topiques contenant olopatadine destinees au tritement d'affections allergiques des yeux
ATE121295T1 (de) Augentropfenarzneimittel.
FI951856A0 (fi) Farmaseuttinen koostumus osteoporoosin hoitamiseksi
CA2157142A1 (en) Treatment of diseases caused by sebaceous gland disorders
EP0842923A4 (en) PYRROL DERIVATIVES AND MEDICAL PREPARATION.
HUP0100024A3 (en) Pharmaceutical compositions for treating alzheimer's disease containing carvedilol as active ingredient
BR9607541A (pt) Tratamento de doenças que tem por causa o fator de crescimento da citoquina
DE69620573D1 (de) Mittel zur verminderung des augeninnendrucks
EP0826373A4 (en) PREVENTION OF POST-OPERATIVE ASTIGMATISM
CA2237643A1 (en) Therapeutic agent for acute hepatic failure